This fat maldistribution was associated with a reduction in plasma adiponectin (Supplementary Fig. 4i), and an increase in obesity-induced glucose intolerance (Supplementary Fig. 4f) and hepatic triglyceride accumulation (Supplementary Fig. 4h). This evidence concerns the gene ADIPOQ and Glucose intolerance.